Microvascular functions have been shown to be sensitive to agents associated with changes in cyclic nucleotide levels. The central hypothesis of the current study was that one measure of capillary exchange capacity, hydraulic conductivity (Lp), would be elevated by agents shown to elevate cellular levels of cGMP. To evaluate the hypothesis, frog mesenteric capillary Lp was measured during luminal exposure to 1) atrial natriuretic peptide (ANP), 2) the truncated atriopeptins ANP-I and ANP-III, 3) the nitrovasodilator sodium nitroprusside (SNP), 4) the cGMP phosphodiesterase inhibitor M&B 22948, and 5) methylene blue dye, both alone and in combination with ANP or SNP. ANP (100 nM) elevated Lp by 2.3+0.2-fold from control levels (n=15); 10 nM ANP induced a 2.1+0.3-fold change (n=8), while 10 nM ANP-III elicited a 1.7+0.4-fold change (n=8). In contrast, Lp did not change from basal levels during 10 nM ANP-I infusion (Lp ''/Lpcontl =1.2±0.2; n=14). SNP (1 ,lM) induced a reversible, 2.6+0.5-fold increase in Lp (n=30) that was inhibitable by methylene blue dye (L SNP+MetB/L pcnt"=1.L+0.1; n=8). Methylene blue did not mask the response to 100 nM ANP (LpANP+MetB/Lpcontrol=2.1+0.5; n=7). M&B 22948 (30 uM) increased Lp by 2.8+0.6-fold (n=9). These data constitute strong inference that agents demonstrated to elevate cGMP also mediate an increase in capillary L p in in situ, perfused exchange vessels. (Circulation Research 1992;70:382-391) At the level of the capillary vasculature, cyclic nucleotide-dependent agents have been shown to alter both hydraulic conductivity (LP)1-3 and solute permeability properties.4,5 cAMP and cGMP both mediate responses to agents of endocrine, paracrine, inflammatory, and synthetic nature. This study addresses the potential role for cGMP in the regulation of capillary Lp. We tested specifically the hypothesis that vasodilators shown to elevate cGMP in vitro increase Lp from basal levels.
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All experiments were carried out in situ in perfused capillaries of the frog mesentery. Lp changes (after a control measurement) were measured during luminal exposure to 1) atrial natriuretic peptide (ANP); 2) the truncated atriopeptins ANP-I and ANP-III; 3) sodium nitroprusside (SNP); 4) the inhibitor of the soluble guanylate cyclase methylene blue; and 5) the cGMP phosphodiesterase inhibitor M&B 22948.
The vasorelaxant, ANP, increases the Lp in capillaries of frog mesentery,1,6 an observation consistent with the peptide's ability to reduce circulating plasma volume by increasing nonrenal vascular fluid efflux. 7, 8 Two distinct receptors for ANP are encountered consistently at the cytoplasmic membranes of mammalian tissues, including vascular endothelium and smooth muscle.9'10 The larger, less abundant receptor activates the membrane-associated, particulate form of guanylate cyclase.9 A "clearance" function has been proposed for the smaller binding site, which binds the truncated atrial peptin ANP-I with higher avidity than ANP-IIJ or the intact peptide ANP, but is without influence on guanylate cyclase activity." In the case of SNP, a member of the class of nitrovasodilators that relaxes vascular smooth muscle by elevating cGMP, NO is released from the agent and diffuses into the vascular wall to activate the cytosolic form of guanylate cyclase.12 The vital dye methylene blue inhibits activation of the soluble guanylate cyclase by NO,13 thereby inhibiting the relaxation of vascular smooth muscle by agents including SNP.14,15 Methylene blue is without influence on particulate guanylate cyclase activity.
M&B 22948, on the other hand, reduces cGMP breakdown by preferential inhibition of the cGMPspecific form of phosphodiesterase (type I). 16 Like the nitrovasodilators, M&B 22948 also relaxes vascular smooth muscle.14 In vitro studies have demonstrated that cellular cGMP is elevated by 1) ANP via activation of the particulate form of guanylate cyclase; 2) SNP by stimulating the soluble form of guanylate cyclase, an action that can be blocked by methylene blue dye; and 3) M&B 22948 via inhibition of cyclic nucleotide phosphodiesterase. ANP-I has been shown to be less potent than ANP-III or ANP in its ability to bind to cultured endothelial cells or in its ability to stimulate cGMP. 15 Our results demonstrate that ANP, ANP-III, SNP, and M&B 22948 acutely elevate exchange vessel Lp from basal levels. The magnitudes of the Lp responses are similar to those observed previously with ANP.6 ANP-I perfusion failed to elicit a change in Lp from basal levels. Although the effects of ANP and SNP are fully reversible, only the SNP response is inhibited by perfusion with methylene blue. Furthermore, a differential, graded sensitivity to SNP is observed that is similar in nature to that observed previously with ANP.4 In general, vessel segments from the low pressure end of the exchange vascular network exhibit the greatest increases in Lp for a given dose of SNP. These results provide, by strong inference, evidence that cGMP mediates an increase in capillary exchange capacity as monitored by an elevation of capillary Lp,. A role for vasorelaxants in the modulation of capillary Lp is proposed.
Materials and Methods

Experimental Preparation
All experiments were performed in situ on mesenteric microvessels of North American leopard frogs (Rana pipiens, 6.5-7 cm body length; J.M. Hazen, Alburg, Vt., and William A. Lemberger Co., Inc., Oshkosh, Wis.). The frogs were housed at 15°C in tanks containing fresh water and damp terrain. The animals were anesthetized by cerebral pith, and care was taken to leave the spinal cord intact. A loop of intestine was exteriorized through a right lateral incision of the abdominal side wall and floated out over a polished quartz pillar (Herus-Amersil, Duluth, Ga.). Throughout each experiment, the mesentery was superfused with air-equilibrated frog-Ringer's solution at pH 7.4 and 15±2°C.
Solutions
Frog-Ringer's solutions were prepared daily and contained (mM) NaCl 111.0, KCl 2.4, MgSO4 1.0, CaCl2 1.1, glucose 5.0, NaHCO3 0.2, and HEPES/Na-HEPES 5 mM. The osmolarity of the solutions was 230 mosm; the pH was 7.40+0.02 (SD) at 15°C and was determined by adjusting the ratio of HEPES acid to Na-HEPES salt.
All perfusate solutions contained bovine serum albumin (BSA; Sigma Chemical Co., St. Louis, Mo.) dialyzed in 12,000 MW cutoff tubing (Spectra/por) against three changes of Ringer's solution over 72 hours (4°C). Protein content of stock solutions was confirmed by a colorimetric Coomassie brilliant blue-protein binding microassay (Bio-Rad Laboratories, Richmond, Calif.). All stock solutions were filtered (0.2-,tm pore diameter; Gelman Sciences Inc., Ann Arbor, Mich.) and were stored at -15°C. Once thawed, solutions were maintained on ice and discarded within 24 hours. Human ANP (28 amino acids) and rat atriopeptin-I (ANP-I; amino acids 5-25) and atriopeptin-III (ANP-III; amino acids 5-28) were obtained from Calbiochem Corp., La Jolla, Calif. SNP and methylene blue dye were obtained from Sigma. Care was taken to minimize light exposure of solutions containing SNP. The cGMP phosphodiesterase inhibitor M&B 22948 was a gift from Rhone-Poulenc, UK.
On the day of an experiment, a small number of washed human erythrocytes were suspended in the perfusate solutions (1-3% [vol/vol]) for use as flow markers.
Determination of Single Microvessel Hydraulic Conductivity
Single vessel Lp was determined using the modified Landis micro-occlusion technique. This method has been described in detail. 17, 18 The mesenteric microvessels, viewed under a Leitz Diavert microscope (magnification, x 75-125), chosen for study were long (>900 ,um), patent, unbranched, and free of leukocytes sticking or rolling on the walls. One or occasionally two vessels per mesentery were used for experimentation. Each vessel was cannulated with a beveled glass micropipette (8-20-,um tip diameter) and perfused with a frog-Ringer's solution containing 10 mg/ml BSA and marker red blood cells. During each cannulation, perfusion pressure was varied between 10 and 35 cm H20. The image of the cannulated perfused capillary was recorded by closed-circuit television (DAGE-MTI 650 camera, Panasonic AG-6300 video recorder) along with the image of a video timer (FOR-A). Downstream from the cannulation site, external pressure was applied by a second micropipette to occlude the vessel. At this point, the hydrostatic pressure in the vessel lumen (Pj) was determined by the perfusion manometer. 
where PC-Pi (AP) and [I-,-Hi (AUi) represent the hydrostatic and osmotic pressure (centimeters of water) differences, respectively, between vessel lu-Qv/S)i = (dx/dt)i(r/2x0) men and mesenteric interstitium; ar is the reflection coefficient to plasma proteins. Lp was calculated as the slope of the relation between JJiS and Pc, assuming a negligible Pi and essentially constant product cr(II-IJli) after occlusion. The assumptions and limitations of this method have been reviewed.17 '18 Classification of Vessel Type The classification scheme based on flow patterns was used to identify capillary type (i.e., arteriolar, true, or venular capillary).19,20 Briefly, capillaries with divergent flow at junctions upstream and downstream from the cannulation site were labeled "arteriolar" capillaries. Those with divergent flow upstream and convergent flow downstream were labeled "true" capillaries. "Venular" capillaries had convergent flow both upstream and downstream from the cannulation site. Recovery Lp measurements were obtained in five of nine vessels. A fourth set of 24 vessels were perfused with methylene blue: nine vessels were perfused with 10 ,uM methylene blue after control perfusion; eight were perfused with methylene blue and SNP before perfusion with SNP alone; and seven vessels were perfused with methylene blue and ANP before perfusion with ANP alone. Finally, for the studies with the atriopeptins, a fifth set of 14 vessels were perfused with 10 nM ANP-I before 10 nM ANP (n=8) and/or 10 nM ANP-III (n=8). Eight vessels were perfused with 1 luM SNP and 100 nM ANP (Table 1 ). Lp was measured first during perfusion with control, frog-Ringer's solution, and 10 mg/ml BSA and then twice more during SNP or ANP perfusion. Four of eight vessels were exposed to ANP before SNP. The perfusion order was reversed for the second set of four vessels. Exposure to ANP before SNP resulted in 2.5+0.3and 2.6+0.7-fold increases in Lp; SNP before ANP resulted in 2.8+0.8-and 2.3±0.7-fold increases in Lp, respectively. Irrespective of perfusion order, SNP and ANP exposure resulted in 2.7±0.5and 2.4+0.3-fold increases in Lp, respectively.
Statistics
The reversibility of the Lp response to SNP perfusion is shown in Figure 2 . Recovery Lp measurements were obtained in six of 30 vessels represented in lary network, Lp tends to be higher in vessels that constitute the venular (i.e., low pressure) end of the exchange network (see Figure 6 ).6,17,21 In the present study, the largest-fold increases in Lp were observed in vessels classified as venular capillaries (Figure 3 ). As a group, the responses of the venular capillaries to SNP perfusion were greater than those of the true capillaries (3.8± +1.1-fold versus 1.7±+0.2-fold; n = 13 for each). The arteriolar capillaries did not respond to SNP (0. (Figure 4 ). Although the number of vessel segments was insufficient to determine whether the responses to ANP-III were a function of segment position in flow, the response of the three arteriolar capillaries to ANP-III did not differ from control Lp (L ANP-111/L control = 1.0±0.3; n=3), whereas combined response of the three venular capillaries and two true capillaries was a 2.1±0.5-fold rise in Lp (see also the absolute values of Lp in Figure 6 ). Seven of the above vessels were perfused with ANP-I before ANP-I1I. In Figure 4 .
Influence of Methylene Blue on Basal Hydraulic Conductivity and on the Actions of Sodium Nitroprusside and Atrial Natriuretic Peptide
To determine whether infusion of capillaries with methylene blue dye influenced the basal level of Lp, Lp was measured in eight vessels during control perfusion and again during perfusion with 10 ,.M methylene blue ( Table 2 ). Lp during dye perfusion did not differ from control levels (L MetB/L control=0.97±0.16; filled circles, Figure 5 ). In seven vessels, control perfusion was followed by perfusion with 100 nM ANP and 10 ,uM methylene blue and finally perfusion with 100 nM ANP alone ( Table 2) . During ANP and methylene blue perfusion, Lp was elevated by 2.1±0.5-fold from control levels; Lp was sustained at 2.3±0.3-fold above control levels during subsequent perfusion with the peptide alone (filled circles, Figure 5 ). The responses during ANP perfusion, both with and without methylene blue, differed significantly from control levels but not from each other.
Eight vessels were perfused with control solution, a second time with 10 ,uM methylene blue and 1 ,uM SNP, and a third time with 1 ,uM SNP alone ( Table 2) .
Lp remained at control levels during perfusion with SNP and methylene blue (L MetB+SNP/L wntrol = 1+0 1) Perfusion of these vessels with SNP induced a subsequent, significant 1.7±0.2-fold increase in Lp from basal levels (open circles, Figure 5 ). Influence (Table 3 ).
Discussion
Cyclic nucleotides mediate a variety of responses in circulatory components containing smooth muscle. Capillaries, by definition, are devoid of smooth mus- The atriopeptins also bind to receptors that bind ANP, but with differing avidity. ANP-I, in particular, binds to the so-called "clearance" receptor, an action not associated with increases in cellular levels of cGMP.11,25 ANP-III binds to the receptor linked to the particulate form of the guanylate cyclase, an action linked with elevated cytosolic cGMP.9,25 In contrast, SNP releases NO, which in turn activates the cytoplasmic or soluble form of guanylate cyclase.12 M&B 22948 elevates cGMP levels by inhibiting cyclic nucleotide phosphodiesterase activity.14 '16 Thus, observations from the current study constitute strong inference in support of cGMP mediation in the mechanisms involved in increasing capillary Lp from basal levels.
Comparison of the Actions ofAtrial Natriuretic Peptide, Sodium Nitroprusside, and M&B 22948
In the present study, no change in arteriolar capillary Lp was observed during SNP perfusion; true capillaries responded with a 75% Lp increase, and venular capillaries responded with a greater than 250% elevation in Lp (Figure 4 ). Thus, a "graded" response to SNP was observed with progression from the high pressure to the low pressure end of the capillary network. Both SNP and ANP effected a change in microvessels at the venular end of the capillary bed and were relatively ineffective at the arterial end. Similarly, the arteriolar capillary segments did not display a change in Lp during ANP-III perfusion, while the true and venular capillary seg- ments did ( Figure 6 ). These results differ from the observations of Clough,26 who found no response to ANP-III perfusion and a rise of venular capillary Lp to ANP only at micromolar doses in vessels with basal Lp values that ranged from 1xl10`to 87x1Q0c mxsec-lxcm H20-1. These apparent differences could have occurred if the perfusate albumin contained small molecular weight components27 or if the frogs were in a relatively volume-expanded state.28
Given that SNP is a receptor-independent activator of cytosolic guanylate cyclase,12 it is unlikely that the common sensitivity of Lp to ANP, ANP-1II, and SNP with capillary type is a consequence of a graded distribution of ANP receptors favoring a higher density of particulate guanylate cyclase-linked receptors in the venular capillaries and a higher density of clearance receptors in the arterial capillaries.9 On the other hand, M&B 22948 elevated Lp without regard to vessel subclassification; these results lead to the inference that the distributed characteristic is at the level of phosphodiesterase activity. One possible mechanism that would give rise to this behavior would be if the activity or content of the phosphodiesterase in the arteriolar capillaries was great enough to prevent accumulation of cGMP to levels required to effect a change in barrier permeability.
Control Lp increases generally with position in a capillary network from arteriolar capillaries to venular capillaries ( Figure 6 ).61721 Although it follows that the Lp response to SNP or to ANP6 should be correlated with initial Lp, no overall correlation was observed. The lack of such a correlation appears to be a consequence of the overlap in the distributions of control Lp values for each capillary subtype.
The action of SNP on Lp was fully reversible. We noted, though, that the perfusion period required for complete recovery was often several minutes longer than the time usually required for recovery from ANP or ANP-IJI perfusion (1-2 minutes). Indeed, during both SNP and M&B 22948 perfusion, the vessels appeared more fragile than with ANP perfusion.16
Methylene Blue as an Agent to Separate Actions Attributable to Soluble Guanylate Cyclase Activation From Particulate Guanylate Cyclase in the Increase in Hydraulic Conductivity The actions of the vascular smooth muscle relaxants, nitrous oxide and nitroso compounds (e.g., glyceryl trinitrate, azide, and nitroprusside), resulting in activation of soluble guanylate cyclase and accumulation of cGMP have been shown to be antagonized by hemoglobin, myoglobin, and methylene (Figure 5 ). The actions of the dye were not detrimental to capillary barrier function because removal of the dye was associated with sustained action of peptide infusion in the first case and unmasking of SNP response in the second case ( Figure 5 ). Two major binding sites for ANP have been identified on endothelium and vascular smooth muscle in addition to cells from numerous other nonvascular sites.9"111530 The smaller, more abundant site binds the ANP-I with higher avidity than it does with ANP-III or ANP. 25 Binding of ANP and ANP-III to the larger binding site is associated with an increase in the accumulation of cGMP via stimulation of particulate guanylate cyclase, whereas ANP-I is orders of magnitude less potent in its ability to stimulate cGMP.9"1125 In the present study equimolar quantities of ANP-III and ANP were both capable of eliciting an increase in Lp, whereas ANP-I at the same dose did not elicit a change in Lp (Figure 4) .
The same vessels that did not demonstrate a change during ANP-I perfusion showed increases in Lp when the perfusate contained ANP-III in one case or ANP in the second case. The rise in Lp during ANP perfusion appears to occur via an increase in the effective area available for transcapillary water movement without influencing macromolecule (protein) selectivity.27'31'32 Interendothelial junctions constitute the principal pathway for transcapillary fluid transport.33 Thus, with high probability, ANP is altering the dimensions of this pathway. SNP, ANP, and M&B 22948 are all vasorelaxants.12"4 We thus hypothesize that these agents increase Lp by relaxation of one or both of the two cellular components of the capillary wall: endothelium and pericytes. In frog mesentery, up to 40% of capillary endothelium is ensheathed by pericytes.20 In the kidney, mesangial cells (pericytes) have been studied because of the presence of contractile elements that provide a mechanism to control the permeability properties of the microvascular barrier. 34, 35 Indeed, both ANP and SNP relax cultured mesangial cells.30 Further, in the renal vasculature, the cGMP target kinase, protein kinase G, is selectively concentrated in contractile cells, including mesangial cells.36 Detectable amounts of protein kinase G are not observed in renovascular endothelial cells.36 Endothelial cells themselves, though, possess actinomyosin filaments2'4 and may contract in vivo.37 Thus, alterations in microvascular permeability properties may well involve the interaction of both cellular components of the transcapillary barrier.
A number of other vasodilatory stimulants have been shown to elevate capillary Lp and/or small solute permeability: acetylcholine,3 histamine,5 sero-tonin,4 bradykinin,4 and the ionophore A23187.2,4,5 These substances are capable of triggering the release of endothelium-derived relaxing factor,4'24 which in turn elevates the cellular levels of cGMP in smooth muscle, ultimately resulting in relaxation.'224
Although histamine and bradykinin are vasodilators of peripheral vessels, their action with regard to microvascular permeability properties is considered inflammatory. Gross morphological changes in the structure of the capillary barrier are observed with the formation of gaps between cells. Therefore, a distinction may be drawn between the magnitude of Lp change observed in the current work with the gross permeability changes observed when diapedesis and macromolecular leakage occur. Such gaps are generally observed in venular microvessels and, relative to the total length of endothelial junction in a capillary bed, are an infrequent occurrence. 35 Further, the gaps are between 0.1 and 1 g,m wide and would result in immeasurably large Lp changes in single capillaries. Histamine in hamster cheek pouch5 and the mast cell degranulating agent 48/80 in frog mesentery2 have more subtle effects on individually perfused capillaries, reversibly elevating large solute permeability and apparent Lp by twofold to fivefold.
Thus, while gap formation is believed to involve endothelial or pericyte contractions,1735 Lp changes are observed in the absence of gap formation and thus appear to involve a separate set of mechanisms.5
